Smith & Nephew (SN) Receives a Buy from Citi

In a report released today, Veronika Dubajova from Citi maintained a Buy rating on Smith & Nephew, with a price target of £16.00.

Claim 50% Off TipRanks Premium and Invest with Confidence

• Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential

Dubajova covers the Healthcare sector, focusing on stocks such as Smith & Nephew, GN Store Nord, and Straumann Holding AG. According to TipRanks, Dubajova has an average return of -5.4% and a 43.05% success rate on recommended stocks.

In addition to Citi, Smith & Nephew also received a Buy from Bank of America Securities’s Julien Ouaddour in a report issued on December 9. However, on the same day, Barclays maintained a Hold rating on Smith & Nephew (LSE: SN).

Based on Smith & Nephew’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of p2.99 billion and a net profit of p295.65 million. In comparison, last year the company earned a revenue of p2.83 billion and had a net profit of p214 million

Based on the recent corporate insider activity of 74 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SN in relation to earlier this year.